Repligen (NASDAQ: RGEN) reported Q1 EPS of $0.39, $0.04 better than the analyst estimate of $0.35. Revenue for the quarter came in at $169 million versus the consensus estimate of $163.4 million.

GUIDANCE:

Repligen sees FY2025 EPS of $1.63-$1.72, versus the consensus of $1.71.

For earnings history and earnings-related data on Repligen (RGEN) click here.